Niall Condon joined Curia as president in July 2022. He is responsible for its manufacturing division, including global API and drug product manufacturing, bringing extensive experience and an established record of success leading global teams across all parts of the biopharmaceutical supply chain.
Niall most recently served as head of API and OSD Manufacturing at Viatris, which was formed through the merger of Mylan and Upjohn Pfizer. Previously, he was a senior vice president at Pfizer, where he built a standalone global supply organization, the Upjohn Division. Niall spent more than 30 years at Pfizer in roles of increasing responsibility in manufacturing and operations, based at locations in the U.S., Europe and Asia.
Niall earned his Bachelor of Science in Chemical Engineering at Munster Technological University, Ireland, and his Master of Business Administration at Rensselaer Polytechnic Institute, New York.